
Biotech 2050 Podcast
Dr. Dave Bearss, Co-Founder & CEO of Halia, on Pioneering Genetic Discoveries to Defeat Alzheimer’s
Oct 4, 2024
Dr. David Bearss, a serial entrepreneur and pharmaceutical innovator, dives into Halia Therapeutics' pioneering efforts against Alzheimer’s disease. He shares personal motivations stemming from family health struggles and discusses the impressive shift in focus from cancer research to combating neuroinflammation. Bearss highlights the unique challenges biotech startups face, stressing the importance of adaptability and a strong team culture. He also reflects on strategic partnerships crucial for innovative drug development, revealing insights into the future of healthcare.
35:36
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Dr. Bearss highlights the importance of personal motivation and mentorship in driving scientific innovation and therapeutic advancements in biotech.
- The discussion emphasizes the critical role of effective time management and strategic hiring in balancing entrepreneurial responsibilities with scientific integrity.
Deep dives
Personal Motivation and Career Path
The speaker shares a deeply personal journey that sparked his interest in the biotech field, rooted in family experiences with cancer. The early loss of his grandfather and later his mother to colon cancer shaped his desire to contribute to the fight against the disease. This profound motivation led to a commitment to make scientific discoveries that could translate into new therapeutics. Through significant mentorship and firsthand involvement in clinical trials, he transitioned from academia to entrepreneurship, ultimately starting several biotech companies focused on improving cancer treatment.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.